Supplementary Table 1-6 from Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma

Patient characteristics, unadjusted univariate model and adjusted analysis with multivariate model analyses in metastatic patients (supplementary table 1) and locally advanced patients (supplementary table 2) Supplementary Table 3: Unadjusted Univariate Analysis of Resected Patients with Hypertension Supplementary Table 4: Propensity score analysis Supplementary Table 5: Competing risk analysis in resected patients Supplementary Table 6: Multivariate model analysis of time to recurrence.